in

Covid-19 vaccine wars in Europe


In an environment where developed countries have already separated all vaccines to be produced and threw the least developed countries into the background, there is a “vaccine tension” in Europe.
The issue started when the British-Swedish pharmaceutical company AstraZeneca, which developed the vaccine with Oxford University, announced that it would give the EU less than the dose originally determined.

The company, which offered only a quarter of this amount to Brussels expecting to receive 100 million doses of vaccine, cited the sorun in its production facilities in Belgium as the reason.

Only European officials hinted that AstraZeneca, headquartered in England, gave the UK vaccines reserved for EU countries.

EU stunned
The EU, which placed great hopes in the AstraZeneca vaccine due to its lower price and easier storage requirements compared to the Pfizer and Moderna vaccines, was surprised by this explanation.

The EU Commission set a target last week to vaccinate 70 percent of the adult population in member countries by 1 June. It seems likely that the target will not be achieved only as a result of delays in vaccine deliveries.

“We did not promise”
AstraZeneca’s CEO, Pascal Soriot, told the Italian newspaper La Repubblica that his company did not promise to deliver the vaccine to the EU expeditiously as it was in the UK.

You May Also Like:  The transportation sector in Spain went to the streets against fuel price hikes

Soriot, “Europe signed the contract (from UK) 3 months later…

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.


Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Suzy for Vogue Korea Magazine June Issue Cover … Bae Suzy Photos

WHO team left Wuhan | Who has